Cargando…
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
Autores principales: | Eisenhut, Katharina, Buchka, Stefan, Eichhorn, Peter, Meier, Harald, Albashiti, Fady, Mansmann, Ulrich, Schlüter, Miriam, Havla, Joachim, Kümpfel, Tania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491170/ https://www.ncbi.nlm.nih.gov/pubmed/34609601 http://dx.doi.org/10.1007/s00415-021-10818-w |
Ejemplares similares
-
Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis
por: Gernert, Jonathan A., et al.
Publicado: (2023) -
Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts
por: Schlüter, Miriam, et al.
Publicado: (2021) -
Neurological manifestations in autoinflammatory syndromes: a series of 131 patients from our neuroimmunology departement
por: Schuh, E, et al.
Publicado: (2015) -
Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants
por: Mulazzani, Elisabeth, et al.
Publicado: (2020) -
Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?
por: Havla, Joachim, et al.
Publicado: (2013)